AVTH .005 the most undervalued bio stock developing drug capridine for prostate cancer : Investors and government agencies, including the Department of Defense and National Institutes of Health, have invested over $7 million into developing and testing Capridine-ß
All posts are my opinion and are not recommendations to buy or sell
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.